| Literature DB >> 27690091 |
Nuno Mendonça1,2,3, John C Mathers4,5,6, Ashley J Adamson7,8,9, Carmen Martin-Ruiz10, Chris J Seal11,12, Carol Jagger13,14, Tom R Hill15,16,17.
Abstract
Very old adults are at increased risk of folate and vitamin B12 deficiencies due to reduced food intake and gastrointestinal absorption. The main aim was to determine the association between folate and vitamin B12 intake from total diets and food groups, and status. Folate or vitamin B12 intakes (2 × 24 h multiple pass recalls) and red blood cell (RBC) folate or plasma vitamin B12 (chemiluminescence immunoassays) concentrations were available at baseline for 731 participants aged 85 from the Newcastle 85+ Study (North-East England). Generalized additive and binary logistic models estimated the associations between folate and vitamin B12 intakes from total diets and food groups, and RBC folate and plasma B12. Folate intake from total diets and cereal and cereal products was strongly associated with RBC folate (p < 0.001). Total vitamin B12 intake was weakly associated with plasma vitamin B12 (p = 0.054) but those with higher intakes from total diets or meat and meat products were less likely to have deficient status. Women homozygous for the FUT2 G allele had higher concentrations of plasma vitamin B12. Cereals and cereal products are a very important source of folate in the very old. Higher intakes of folate and vitamin B12 lower the risk of "inadequate" status.Entities:
Keywords: FUT2; MTHFR; Newcastle 85+ Study; food groups; red blood cell folate; vitamin B12; ‘aged 80 and over’
Year: 2016 PMID: 27690091 PMCID: PMC5083992 DOI: 10.3390/nu8100604
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Population characteristics, folate and vitamin B12 intakes and biomarkers of one carbon metabolism in the Newcastle 85+ Study.
| All | Men | Women | ||
|---|---|---|---|---|
| Sex (%) ( | 732 | 39 (287) | 61 (445) | - |
| BMI (kg/m2) (mean ± SD) | 24.4 ± 4.3 | 24.7 ± 3.9 | 24.3 ± 4.6 | 0.244 2 |
| Smokers (%) ( | 5.6 (41) | 4.2 (12) | 6.5 (29) | 0.183 |
| Alcohol Drinkers (%) ( | 72 (364) | 84 (192) | 62 (172) | <0.001 |
| Total Energy Intakes (MJ/day) | 6.78 (5.62–8.31) | 8.01 (6.65–9.59) | 6.26 (5.17–7.38) | <0.001 |
| Folate and vitamin B12 supplement use (%) ( | 4.8 (35) | 3.8 (11) | 5.4 (24) | 0.334 |
| H2 antagonists, PPI and biguanides use (%) ( | 26.8 (196) | 27.2 (78) | 26.5 (118) | 0.844 |
| Total Homocysteine (µmol/L) | 16.7 (13.5–21.4) | 18.0 (14.5–21.9) | 16.1 (13.1–21.0) | 0.001 |
| >15 µmol/L (%) ( | 63.1 (471) | 70.3 (206) | 58.5 (265) | 0.001 |
| Intake (µg/day) | 209 (157–265) | 246 (185–296) | 189 (144–242) | <0.001 |
| <100 µg/day (%) ( | 3.1 (23) | 0.7 (2) | 4.7 (21) | 0.002 |
| Top food group contributors | Cereals (32%), Vegetables (16%), Fruit (9%) | Cereals (32%), Vegetables (15%), Fruit (8%) | Cereals (31%), Vegetables (17%), Fruit (10%) | - |
| Red Blood Cell Folate (nmol/L) | 863 (451–1287) | 868 (596–1282) | 854 (614–1287) | 0.728 |
| <340 nmol/L (%) ( | 3.6 (26) | 2.1 (6) | 4.5 (20) | 0.103 |
| Intake (µg/day) | 2.9 (1.9–4.4) | 3.5 (2.2–5.2) | 2.5 (1.6–3.9) | <0.001 |
| <1.0 µg/day (%) ( | 9.2 (67) | 4.5 (13) | 12.1 (54) | <0.001 |
| Top food group contributors | Meat (53%), Fish (17%), Milk (13%) | Meat (59%), Fish (16%), Milk (10%) | Meat (48%), Fish (19%), Milk (15%) | - |
| Plasma Vitamin B12 (pmol/L) | 232 (170–324) | 228 (166–309) | 238 (174–337) | 0.238 |
| <148 pmol/L (%) ( | 17.1 (125) | 17.4 (50) | 16.9 (75) | 0.841 |
BMI, body mass index; Cereals, Cereals and cereal products; Fruit, Fruit and fruit juice; Meat, Meat and meat products; Fish, Fish and fish dishes; Milk, Milk and milk products; PPI, proton pump inhibitors. Values are medians and IQR unless otherwise stated. 1 No sex difference by Chi-squared test (χ2) for categorical or Mann–Whitney test for non-parametric continuous variables; 2 Independent t-test.
Plasma vitamin B12 and RBC folate concentrations by FUT2, MTHFR, MTR, and TCN1 genotypes in the Newcastle 85+ Study.
| RBC Folate (nmol/L) | Plasma Vitamin B12 (pmol/L) | |||
|---|---|---|---|---|
| 0.531 | <0.001 | |||
| AA ( | 894 (629–1349 | 216 (146–281) | Ref. | |
| A/G ( | 917 (603–1322) | 221 (163–309) | 0.413 | |
| GG ( | 835 (595–1206) | 277 (209–381) | <0.001 | |
| 0.028 | 0.244 | |||
| GG ( | 871 (614–1275) | Ref. | 234 (168–331) | |
| A/G ( | 845 (584–1263) | 1.000 | 230 (164–312) | |
| AA ( | 1010 (693–1626) | 0.060 | 249 (193–339) | |
| 0.547 | 0.277 | |||
| AA ( | 881 (613–1278) | 240 (173–337) | ||
| A/G ( | 845 (596–1332) | 226 (162–297) | ||
| GG ( | 1053 (580–1593) | 247 (162–310) | ||
| 0.065 | 0.298 | |||
| AA ( | 877 (606–1317) | 237 (178–336) | ||
| A/G ( | 845 (595–1223) | 231 (160–325) | ||
| GG ( | 1074 (630–1439) | 222 (182–273) | ||
RBC folate, Red blood cell folate; FUT2, Fucosyltrasnferase 2; MTHFR, Methylenetetrahydrofolate reductase; MTR, Methionine synthase; TCN1, Transcobalamin 1. Ref., Reference used for post hoc comparisons. 1 Kruskal–Wallis test followed by Dunn–Bonferroni post-hoc test if the null hypothesis was rejected.
Figure 1Estimated difference from the mean (and 95% CI) of RBC folate concentration according to folate intake from A. all dietary sources, B. from cereals and cereal products, C. from fruit and fruit juice and D. from vegetables. Generalized additive model (gam) adjusted for sex, energy intake, MTHFR genotype, folic acid supplement use and folate intake from the two other food sources. The highest 2.5th percentiles of RBC folate concentrations are not included. Three participants with a folate intake above 150 µg only from vegetables were not included. One participant with a folate intake of 327 µg only from fruit and fruit juice was excluded. p values are from the corresponding gam model.
Odds ratio (95% CI) of low RBC folate concentration according to quartiles of total folate intake and intakes from cereals and cereal products, from vegetables and from fruit and fruit juice in the Newcastle 85+ Study.
| Folate Intake | Model 1 (Unadjusted) | Model 2 (Adjusted) | ||
|---|---|---|---|---|
| Total (µg/day) | <600 nmol/L ( | <600 nmol/L ( | ||
| <157 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 157–208 | 0.64 (0.40, 1.04) | 0.071 | 0.65 (0.38, 1.09) | 0.103 |
| 209–264 | 0.72 (0.45, 1.15) | 0.173 | 0.58 (0.34, 1.02) | 0.057 |
| >264 | 0.58 (0.36, 0.94) | 0.028 | 0.43 (0.23, 0.82) | 0.010 |
| Cereals and Cereal products (µg/day) | <600 nmol/L ( | <600 nmol/L ( | ||
| <36 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 36–59 | 0.96 (0.61, 1.49) | 0.840 | 0.84 (0.51, 1.38) | 0.493 |
| 59–92 | 0.40 (0.24, 0.66) | <0.001 | 0.32 (0.18, 0.57) | <0.001 |
| >92 | 0.41 (0.25, 0.68) | 0.001 | 0.33 (0.18, 0.61) | <0.001 |
| Vegetables (µg/day) | <600 nmol/L ( | <600 nmol/L ( | ||
| <15 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 15–30 | 0.72 (0.43, 1.21) | 0.212 | 0.49 (0.25, 0.95) | 0.035 |
| 30–51 | 0.86 (0.52, 1.41) | 0.550 | 0.59 (0.32, 1.08) | 0.089 |
| >51 | 0.79 (0.48, 1.30) | 0.357 | 0.52 (0.28, 0.99) | 0.045 |
| Fruit and Fruit Juice (µg/day) | <600 nmol/L ( | <600 nmol/L ( | ||
| <7.3 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 7.3–16 | 0.90 (0.53, 1.52) | 0.682 | 1.01 (0.56, 1.83) | 0.979 |
| 16–34 | 0.61 (0.35, 1.07) | 0.086 | 0.67 (0.36, 1.25) | 0.213 |
| >34 | 0.76 (0.44, 1.31) | 0.329 | 0.79 (0.43, 1.44) | 0.437 |
RBC folate, Red blood cell folate; p, p-value. Low folate status was defined as RBC folate concentration <600 nmol/L. Binary logistic regression model. Model 1 is unadjusted and Model 2 is adjusted for sex, energy intake, folate intake from the other two food sources (except for total folate), MTHFR genotype and folic acid-containing supplement use.
Figure 2Estimated difference from the mean (and 95% CI) of plasma B12 concentrations according to vitamin B12 intake from A. all dietary sources, B. from meat and meat products, C. from milk and milk products and D. from fish and fish products. Generalized additive model (gam) adjusted for sex, energy intake, FUT2 genotype, H2 antagonists, proton pump inhibitors or biguanides use, vitamin B12 supplement use and vitamin B12 intakes from the other two food sources. The lowest and highest 2.5th percentiles of vitamin B12 intakes and plasma vitamin B12 concentrations are not included except for meat and meat products where the highest 5th percentile was excluded. p values are from the corresponding gam model.
Odds ratio (95% CI) of plasma vitamin B12 deficiency according to quartiles of intake of total vitamin B12 and intakes from meat and meat products, from fish and fish products, and from milk and milk products in the Newcastle 85+ Study.
| Vitamin B12 Intake | Model 1 (Unadjusted) | Model 2 (Adjusted) | ||
|---|---|---|---|---|
| Total (µg/day) | <148 pmol/L ( | <148 pmol/L ( | ||
| <1.87 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 1.87–2.88 | 0.70 (0.42, 1.18) | 0.180 | 0.57 (0.32, 1.01) | 0.056 |
| 2.88–4.40 | 0.60 (0.35, 1.02) | 0.057 | 0.50 (0.28, 0.92) | 0.026 |
| >4.40 | 0.53 (0.31, 0.92) | 0.024 | 0.40 (0.21, 0.76) | 0.005 |
| Meat and Meat products (µg/day) | <148 pmol/L ( | <148 pmol/L ( | ||
| <0.35 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 0.35–1.03 | 0.72 (0.42, 1.24) | 0.236 | 0.69 (0.38, 1.25) | 0.220 |
| 1.03–2.10 | 0.84 (0.50, 1.44) | 0.533 | 0.78 (0.43, 1.42) | 0.422 |
| >2.10 | 0.55 (0.31, 0.98) | 0.043 | 0.41 (0.20, 0.81) | 0.010 |
| Fish and Fish products (µg/day) | <148 pmol/L ( | <148 pmol/L ( | ||
| <0.46 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 0.46–1.06 | 0.61 (0.23, 1.65) | 0.331 | 0.66 (0.23, 1.91) | 0.444 |
| 1.06–2.45 | 0.86 (0.34, 2.15) | 0.743 | 0.66 (0.23, 1.86) | 0.427 |
| >2.45 | 1.00 (0.41, 2.42) | 0.992 | 0.70 (0.25, 1.97) | 0.503 |
| Milk and Milk products (µg/day) | <148 pmol/L ( | <148 pmol/L ( | ||
| <0.27 | 1.00 (ref.) | - | 1.00 (ref.) | - |
| 0.27–0.53 | 0.84 (0.47, 1.52) | 0.562 | 0.88 (0.46, 1.71) | 0.711 |
| 0.53–0.88 | 1.12 (0.64, 1.96) | 0.698 | 1.28 (0.70, 2.37) | 0.425 |
| >0.88 | 0.58 (0.31, 1.08) | 0.086 | 0.49 (0.24, 1.01) | 0.054 |
p, p-value. Binary logistic regression model. Deficient plasma vitamin B12 concentration was defined as <148 pmol/L. Model 1 is unadjusted and Model 2 is adjusted for sex, energy intake, FUT2 genotype, vitamin B12 intake from the other two food sources (except total vitamin B12 intake), vitamin B12 containing supplement use, H2 antagonists, biguanides and proton pump inhibitors use.